Real-world nivolumab use in melanoma: what happens after surgery?

NCT ID NCT03771859

Completed Knowledge-focused Sponsor: Bristol-Myers Squibb Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study watched 152 melanoma patients who had their tumors surgically removed and then started nivolumab as part of their normal care. Researchers tracked how long patients stayed cancer-free, whether the cancer spread, and overall survival. The goal was to see how well the drug works in everyday practice, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cutaneous melanoma melanoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MELANOMA

Contacts and locations

Locations

Local Institution

Aalst, 9300, Belgium
Local Institution

Antwerp, 2020, Belgium
Local Institution

Bouge, 5004, Belgium
Local Institution

Bruges, B-8000, Belgium
Local Institution

Brussels, 1000, Belgium
Local Institution

Ghent, 9000, Belgium
Local Institution

Hasselt, 3500, Belgium
Local Institution

La Louvière, 7100, Belgium
Local Institution

Sint-Niklaas, 9100, Belgium
Local Institution

Turnhout, 2300, Belgium
Local Institution

Luxembourg, 1210, Luxembourg
Local Institution - 0001

Brussels, Brussels Capital, 1090, Belgium
Local Institution - 0008

Liège, 4000, Belgium
Local Institution - 0014

Edegem, 2650, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.